Here are relevant reports on : grignard-reagent-market
-
Cell Culture Market by Product (Consumables (Media, Sera, Reagent, Vessels (Roller bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), End User - Global Forecast to 2030
The global cell culture market, valued at US$27.92 billion in 2024, stood at US$29.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$50.69 billion by the end of the period. Growing opportunities in emerging economies and advancements in 2D and 3D cell culture technology is likely to offer potential growth opportunities in the cell culture market.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Biopharma) - Global Forecast to 2030
The global proteomics market, valued at US$33.63 billion in 2024, stood at US$36.32 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2025 to 2030, culminating in a forecasted valuation of US$65.80 billion by the end of the period. The major factors driving growth in the proteomics market are the growing demand for personalized medicines for clinical practices, rising applications in drug discovery and development, growing government & private funding, clinical trial and translational research expansion, biologics and biosimilars development, increasing focus on monoclonal antibodies and therapeutic proteins, and improved techniques in protein quantification.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Fire Suppression Market by Product (Fire Suppressors, Fire Detectors and Control Panels, Sprinklers, Nozzles, Caps, and Control Heads), Suppression Reagent, Sector (Residential, Commercial, Industrial), and Region - Global Forecast to 2035
The fire suppression market is estimated to be worth USD 22.97 billion in 2018 and is projected to reach USD 29.13 billion by 2023, at a CAGR of 4.87% between 2018 and 2023. Key factors such as technological advancements and innovations in the construction industry; increasing policies, regulations, and government mandates; and increased damage to human life and property due to fire breakouts are driving the fire suppression market growth. The fire suppression market has been segmented on the basis of suppression reagent, product, sector, and geography. Major companies in the fire suppression market are Johnson Controls (Ireland), United Technologies (US), Robert Bosch (Germany), Siemens (Germany), Halma (UK), Hochiki (Japan), Firefly (Sweden), Minimax Viking (Germany), Honeywell (US), and S&S Fire Suppression Systems (US). Key innovators in the market are EMS Security Group (UK), Electro Detectors (UK), Napco Security Technologies (US), Fike (US), and Gentex (US). Other key players are Noha Norway (Norway), Sterling Safety Systems (UK), FireProTec (US), Fire Suppression Limited (UK), and Encore Fire Protection (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Europe Cell Culture Market, valued at US$8.01 billion in 2024, stood at US$8.50 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.23 billion by the end of the period. The growth of the Europe cell culture market is driven by a strong and expanding biopharmaceutical sector, with rising production of biologics such as monoclonal antibodies, vaccines, and recombinant proteins that rely on sophisticated culture systems.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Healthcare Dispensing Systems Market by Type (Automatic, Manual, Dispensing Component, Control System), Material (Reagent, Antibody, Powder), Application (Drug Delivery, Microfluidics), End User (Hospital, Pharmacy) & Region - Global Forecast to 2030
The global healthcare dispensing systems market, valued at US$4.36 billion in 2024, stood at US$4.61 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$6.27 billion by the end of the period. The market's accelerated growth trajectory is primarily driven by increasing demand for precision dispensing in pharmaceutical manufacturing, diagnostics, and medical device production.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Europe Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Europe Proteomics market, valued at USD9.80 billion in 2024, stood at USD10.55 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of USD18.77 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Asia Pacific cell culture Market, valued at US$6.49 billion in 2024, stood at US$6.98 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$12.40 billion by the end of the period. Biopharma companies in the region are expanding the production of monoclonal antibodies, vaccines, biosimilars, and recombinant proteins based on cell culture in the Asia Pacific cell culture market, which is thus growing.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The North America Cell Culture Market, valued at US$11.10 billion in 2024, stood at US$11.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$20.38 billion by the end of the period. Growth of the North America cell culture market is driven by a strong and expanding biopharmaceutical industry, with rising production of biologics such as monoclonal antibodies, vaccines, and cell-based therapies that rely heavily on advanced culture techniques and systems.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Rapid Microbiology Testing Market by Product (Instruments (Automated Identification System, PCR, Mass Spectrometer) Reagent, Kits), Method (Growth, Nucleic Acid, Viability), Application (Clinical Diagnosis, Industrial, Research) & Region - Global Forecast to 2029
The global rapid microbiology testing market, valued at US$4.7 billion in 2023, stood at US$5.1 billion in 2024 and is projected to advance at a resilient CAGR of 10.1% from 2023 to 2029, culminating in a forecasted valuation of US$8.3 billion by the end of the period.The increasing use of rapid microbiology testing products can be attributed to their ability to provide quick and reliable results. These products are cost-effective and can often lead to cost savings compared to traditional methods, which is a significant factor driving market growth.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Slide Stainer Market by Product (Reagent (Stains, Probes, ABS), Equipment (Automated, Manual)), Technology (H&E, IHC, ISH, Cytology), Application (Disease Diagnosis (Cancer) Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2027
Slide stainer market growth is primed to transition from $4.3 billion in 2022 to $5.9 billion by 2027, showcasing a strong CAGR of 6.8%. The growth in this market is driven by the increasing diagnosis of cancer, infectious, and other chronic diseases, expanding patient base and improving healthcare infrastructure.
- Published: September 2022
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
